LOGIN  |  REGISTER
Surmodics

Recent Insider Transactions - Ligand Pharmaceuticals (NASDAQ: LGND)

Follow NASDAQ:LGND Visit website
Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ LGND Ligand Pharmaceuticals
Aryeh Jason / director
04/30/2024
Buy
$52.30
2,406
$126K
76,828
NASDAQ LGND Ligand Pharmaceuticals
Aryeh Jason / director
04/30/2024
Sell
$52.30
2,406
$126K
0
NASDAQ LGND Ligand Pharmaceuticals
KOZARICH JOHN W / director
04/24/2024
Buy
$39.35
2,893
$114K
42,523
NASDAQ LGND Ligand Pharmaceuticals
KOZARICH JOHN W / director
04/24/2024
Sell
$39.35
2,893
$114K
0
NASDAQ LGND Ligand Pharmaceuticals
Davis Todd C / director, officer: Chief Executive Officer
03/25/2024
Buy
$66.19
3,556
$235K
120,160
NASDAQ LGND Ligand Pharmaceuticals
Davis Todd C / director, officer: Chief Executive Officer
03/25/2024
Buy
$68.51
2,156
$148K
116,604
NASDAQ LGND Ligand Pharmaceuticals
Davis Todd C / director, officer: Chief Executive Officer
03/25/2024
Buy
$67.24
2,855
$192K
114,448
NASDAQ LGND Ligand Pharmaceuticals
Davis Todd C / director, officer: Chief Executive Officer
03/25/2024
Buy
$46.20
7,448
$344K
111,593
NASDAQ LGND Ligand Pharmaceuticals
Davis Todd C / director, officer: Chief Executive Officer
03/25/2024
Sell
$46.20
7,448
$344K
0
NASDAQ LGND Ligand Pharmaceuticals
Davis Todd C / director, officer: Chief Executive Officer
03/25/2024
Sell
$66.19
3,556
$235K
0
NASDAQ LGND Ligand Pharmaceuticals
Davis Todd C / director, officer: Chief Executive Officer
03/25/2024
Sell
$67.24
2,855
$192K
0
NASDAQ LGND Ligand Pharmaceuticals
Davis Todd C / director, officer: Chief Executive Officer
03/25/2024
Sell
$68.51
2,156
$148K
0
NASDAQ LGND Ligand Pharmaceuticals
Sabba Stephen L / director
03/05/2024
Sell
$74.30
1,893
$141K
28,926
NASDAQ LGND Ligand Pharmaceuticals
Sabba Stephen L / director
03/05/2024
Sell
$67.53
2,893
$195K
419
NASDAQ LGND Ligand Pharmaceuticals
Aryeh Jason / director
03/05/2024
Buy
$39.35
2,893
$114K
74,422
NASDAQ LGND Ligand Pharmaceuticals
Aryeh Jason / director
03/05/2024
Sell
$39.35
2,893
$114K
0
NASDAQ LGND Ligand Pharmaceuticals
Reardon Andrew / officer: CHIEF LEGAL OFFICER &
02/27/2024
Buy
$89.20
29,272
$2.611M
29,272
NASDAQ LGND Ligand Pharmaceuticals
Korenberg Matthew E / officer: PRESIDENT & CHIEF OPERATING
02/27/2024
Buy
$89.20
58,544
$5.222M
58,544
NASDAQ LGND Ligand Pharmaceuticals
Espinoza Octavio / officer: Chief Financial Officer
02/28/2024
Buy
$58.49
325
$19K
29,895
NASDAQ LGND Ligand Pharmaceuticals
Espinoza Octavio / officer: Chief Financial Officer
02/28/2024
Sell
$88.46
140
$12K
29,755
NASDAQ LGND Ligand Pharmaceuticals
Espinoza Octavio / officer: Chief Financial Officer
02/28/2024
Buy
$57.22
140
$8K
29,570
NASDAQ LGND Ligand Pharmaceuticals
Espinoza Octavio / officer: Chief Financial Officer
02/28/2024
Buy
$55.75
799
$45K
29,430
NASDAQ LGND Ligand Pharmaceuticals
Espinoza Octavio / officer: Chief Financial Officer
02/27/2024
Buy
$89.20
29,272
$2.611M
29,272
NASDAQ LGND Ligand Pharmaceuticals
Espinoza Octavio / officer: Chief Financial Officer
02/28/2024
Sell
$57.22
140
$8K
7,722
NASDAQ LGND Ligand Pharmaceuticals
Espinoza Octavio / officer: Chief Financial Officer
02/28/2024
Sell
$55.75
799
$45K
2,869
NASDAQ LGND Ligand Pharmaceuticals
Espinoza Octavio / officer: Chief Financial Officer
02/28/2024
Sell
$58.49
325
$19K
1,607
NASDAQ LGND Ligand Pharmaceuticals
Davis Todd C / director, officer: CHIEF EXECUTIVE OFFICER
02/27/2024
Buy
$89.20
131,723
$11.750M
131,723
NASDAQ LGND Ligand Pharmaceuticals
Reardon Andrew / officer: CHIEF LEGAL OFFICER &
02/15/2024
Sell
$74.65
593
$44K
14,997
NASDAQ LGND Ligand Pharmaceuticals
Korenberg Matthew E / officer: PRESIDENT & CHIEF OPERATING
02/15/2024
Sell
$74.65
4,778
$357K
89,445
NASDAQ LGND Ligand Pharmaceuticals
Espinoza Octavio / officer: Chief Financial Officer
02/15/2024
Sell
$74.65
1,479
$110K
21,423
NASDAQ LGND Ligand Pharmaceuticals
Davis Todd C / director, officer: CHIEF EXECUTIVE OFFICER
02/15/2024
Sell
$74.65
1,381
$103K
71,709
NASDAQ LGND Ligand Pharmaceuticals
Korenberg Matthew E / officer: PRESIDENT & CHIEF OPERATING
01/02/2024
Sell
$72.31
2,917
$211K
94,223
NASDAQ LGND Ligand Pharmaceuticals
Reardon Andrew / officer: CHIEF LEGAL OFFICER &
12/29/2023
Buy
$60.71
179
$11K
15,590
NASDAQ LGND Ligand Pharmaceuticals
Espinoza Octavio / officer: Chief Financial Officer
12/05/2023
Sell
$59.61
1,269
$76K
22,902
NASDAQ LGND Ligand Pharmaceuticals
Korenberg Matthew E / officer: PRESIDENT & CHIEF OPERATING
12/05/2023
Sell
$59.61
1,984
$118K
97,140
NASDAQ LGND Ligand Pharmaceuticals
Espinoza Octavio / officer: Chief Financial Officer
10/01/2023
Sell
$59.92
346
$21K
24,171
NASDAQ LGND Ligand Pharmaceuticals
Zimmermann Martine / director
09/22/2023
Buy
$59.08
11,345
$670K
11,345
NASDAQ LGND Ligand Pharmaceuticals
Davis Todd C / director, officer: CHIEF EXECUTIVE OFFICER
09/22/2023
Buy
$59.38
4,000
$238K
73,090
NASDAQ LGND Ligand Pharmaceuticals
Reardon Andrew / officer: CHIEF LEGAL OFFICER &
08/10/2023
Sell
$68.73
897
$62K
15,411
NASDAQ LGND Ligand Pharmaceuticals
Korenberg Matthew E / officer: PRESIDENT & CHIEF OPERATING
06/30/2023
Buy
$56.78
376
$21K
99,124
NASDAQ LGND Ligand Pharmaceuticals
Espinoza Octavio / officer: Chief Financial Officer
06/30/2023
Buy
$56.78
375
$21K
24,517
NASDAQ LGND Ligand Pharmaceuticals
Sabba Stephen L / director
06/09/2023
Sell
$73.76
5,461
$403K
5,461
NASDAQ LGND Ligand Pharmaceuticals
Gray Nancy Ryan / director
06/09/2023
Buy
$73.76
5,461
$403K
5,461
NASDAQ LGND Ligand Pharmaceuticals
LAMATTINA JOHN L / director
06/09/2023
Buy
$73.76
5,461
$403K
5,461
NASDAQ LGND Ligand Pharmaceuticals
KOZARICH JOHN W / director
06/09/2023
Buy
$73.76
5,461
$403K
5,461
NASDAQ LGND Ligand Pharmaceuticals
Aryeh Jason / director
06/09/2023
Buy
$73.76
5,461
$403K
5,461
NASDAQ LGND Ligand Pharmaceuticals
Haas Jason / director
06/09/2023
Buy
$73.76
5,461
$403K
5,461
NASDAQ LGND Ligand Pharmaceuticals
Davis Todd C / director, officer: CHIEF EXECUTIVE OFFICER
06/09/2023
Sell
$73.76
420
$31K
69,090
NASDAQ LGND Ligand Pharmaceuticals
KOZARICH JOHN W / director
05/16/2023
Sell
$77.20
4,444
$343K
38,488
NASDAQ LGND Ligand Pharmaceuticals
Sabba Stephen L / director
05/10/2023
Sell
$77.13
6,408
$494K
25,784
NASDAQ LGND Ligand Pharmaceuticals
Sabba Stephen L / director
05/10/2023
Sell
$18.82
6,408
$121K
927
NASDAQ LGND Ligand Pharmaceuticals
KOZARICH JOHN W / director
05/08/2023
Buy
$18.82
6,408
$121K
48,621
NASDAQ LGND Ligand Pharmaceuticals
KOZARICH JOHN W / director
05/08/2023
Sell
$76.51
5,819
$445K
42,802
NASDAQ LGND Ligand Pharmaceuticals
KOZARICH JOHN W / director
05/08/2023
Sell
$77.10
589
$45K
42,213
NASDAQ LGND Ligand Pharmaceuticals
KOZARICH JOHN W / director
05/08/2023
Sell
$18.82
6,408
$121K
0
NASDAQ LGND Ligand Pharmaceuticals
Reardon Andrew / officer: See Remarks
03/24/2023
Sell
$69.92
300
$21K
16,308
NASDAQ LGND Ligand Pharmaceuticals
Espinoza Octavio / officer: Chief Financial Officer
02/23/2023
Buy
$75.09
16,419
$1.233M
16,419
NASDAQ LGND Ligand Pharmaceuticals
Korenberg Matthew E / officer: President & COO
02/23/2023
Buy
$75.09
24,628
$1.849M
24,628
NASDAQ LGND Ligand Pharmaceuticals
Reardon Andrew / officer: See Remarks
02/23/2023
Buy
$75.09
15,393
$1.156M
15,393
NASDAQ LGND Ligand Pharmaceuticals
Davis Todd C / director, officer: Chief Executive Officer
02/23/2023
Buy
$75.09
46,178
$3.468M
46,178
NASDAQ LGND Ligand Pharmaceuticals
Korenberg Matthew E / officer: President & COO
02/15/2023
Sell
$72.98
2,890
$211K
89,679
NASDAQ LGND Ligand Pharmaceuticals
Espinoza Octavio / officer: Chief Financial Officer
02/15/2023
Sell
$72.98
849
$62K
18,096
NASDAQ LGND Ligand Pharmaceuticals
Espinoza Octavio / officer: Chief Financial Officer
12/30/2022
Buy
$56.78
275
$16K
18,945
NASDAQ LGND Ligand Pharmaceuticals
Korenberg Matthew E / officer: President & COO
12/28/2022
Sell
$66.29
3,859
$256K
92,569
NASDAQ LGND Ligand Pharmaceuticals
HIGGINS JOHN L / director
12/28/2022
Sell
$66.29
5,289
$351K
417,695
NASDAQ LGND Ligand Pharmaceuticals
HIGGINS JOHN L / director
12/22/2022
Buy
$67.03
92,932
$6.229M
92,932
NASDAQ LGND Ligand Pharmaceuticals
Korenberg Matthew E / officer: President & COO
12/22/2022
Buy
$67.03
25,967
$1.741M
25,967
NASDAQ LGND Ligand Pharmaceuticals
KOZARICH JOHN W / director
12/22/2022
Buy
$67.03
6,623
$444K
6,623
NASDAQ LGND Ligand Pharmaceuticals
Gray Nancy Ryan / director
12/22/2022
Buy
$67.03
3,050
$204K
3,050
NASDAQ LGND Ligand Pharmaceuticals
Sabba Stephen L / director
12/22/2022
Buy
$67.03
6,623
$444K
6,623
NASDAQ LGND Ligand Pharmaceuticals
LAMATTINA JOHN L / director
12/22/2022
Buy
$67.03
4,484
$301K
4,484
NASDAQ LGND Ligand Pharmaceuticals
Aryeh Jason / director
12/22/2022
Buy
$67.03
4,484
$301K
4,484
NASDAQ LGND Ligand Pharmaceuticals
Davis Todd C / director, officer: Chief Executive Officer
12/22/2022
Buy
$67.03
2,081
$139K
2,081

COPYRIGHT ©2023 HEALTH STOCKS HUB

  Research Tools
  News & Announcements
  Popular Topics
  Miscellaneous